Pharmaceuticals Inc Ligand serves as Executive at LIGAND PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Pharmaceuticals Inc Ligand has executed 10 insider transactions totaling $7.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 1, 2025 involved exercising options for 1,500,000 shares valued at $15.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 1, 2025 | PTHS | $15.0M | Conversion | 1,500,000 | $10.00 | Discretionary |
| Nov 1, 2022 | NONE | $0 | Other | 16,859,308 |
Pharmaceuticals Inc Ligand currently holds 1,500,000 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharmaceuticals Inc Ligand has been a net seller of LGND stock. They have purchased $0 and sold $7.6M worth of shares.
Pharmaceuticals Inc Ligand's most recent insider trade was on Jul 1, 2025, when they sold 1,500,000 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 26, 2020 | VKTX | $766.3K | Sale | 94,488 | $8.11 | Discretionary |
| Aug 26, 2020 | VKTX | $1.2M | Sale | 148,700 | $8.11 | Discretionary |
| Aug 25, 2020 | VKTX | $561.4K | Sale | 70,000 | $8.02 | Discretionary |
| Sep 25, 2018 | VKTX | $5.0M | Sale | 262,881 | $19.15 | Discretionary |
| Apr 13, 2016 | VKTX | $0 | Award | 560,000 | $N/A | Discretionary |
| Apr 13, 2016 | VKTX | $1.2M | Conversion | 960,000 | $1.25 | Discretionary |
| May 28, 2015 | VKTX | $0 | Other | 228,105 | $N/A | Discretionary |
| Aug 4, 2008 | LGND | $0 | Award | 10,000 | $N/A | Discretionary |